Search terms
Results 1 - 3 of 3 - ordered by :

Patients with AF are reported to have a five-fold increased risk of stroke; moreover, compared with the other identified risk factors for stroke (hypertension, heart failure, and coronary heart ...

Europace, Review, Jean-Pierre Bassand

Date : 01/03/2012 Item size : 404682 bytes

Phase I, baseline cohort before the introduction of non-VKA oral anticoagulants (NOACs); Phase II, just after the introduction of the first NOAC dabigatran, with 2-year follow-up in ...

Europace, CLINICAL RESEARCH, Menno V. Huisman, Chang Sheng Ma, Hans-Christoph Diener, Sergio J. Dubner, Jonathan L. Halperin, Kenneth J. Rothman, Christine Teutsch, Nils Schoof, Eva Kleine, Dorothee ...

Date : 01/09/2016 Item size : 261631 bytes

Randomized trials in patients with atrial fibrillation (AF) have consistently demonstrated that compared with placebo, adjusted-dose vitamin K antagonists (VKAs) reduce the incidence of stroke by ...

Europace, Editorial, Laurent Fauchier, Gregory Y.H. Lip

Date : 01/06/2010